SEC Form 4 · accession 0001437749-17-000152
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E Byrne
Officer — General Counsel
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.26 | Jan 3, 2017 | A | 4,673 | A | — | Jan 3, 2027 | Common Stock | 4,673 | 4,673 | D |
Explanation of responses
- F1The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019.